Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXNB0E
|
||||
Drug Name |
4-allyl-23-oxo-8-oxa-1,15,17,21-tetraazapentacyclo[19.2.2.13,7.19,13.015,19]heptacosa-3(27),4,6,9(26),10,12,16,18-octaen-10-yl cyanide
|
||||
Synonyms |
CHEMBL160223
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C26H25N5O2
|
||||
Canonical SMILES |
C=CCc1ccc2Oc3cc(Cn4cncc4CN5CCN(Cc1c2)C(=O)C5)ccc3C#N
|
||||
InChI |
InChI=1S/C26H25N5O2/c1-2-3-20-6-7-24-11-22(20)15-30-9-8-29(17-26(30)32)16-23-13-28-18-31(23)14-19-4-5-21(12-27)25(10-19)33-24/h2,4-7,10-11,13,18H,1,3,8-9,14-17H2
|
||||
InChIKey |
AEUOJCZWQRBEMN-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.